TA
FLNA

Teton Advisors’s Filana Therapeutics FLNA Stock Holding History

Teton Advisors’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-6,429
Closed -$40K – 431
2017
Q1 		$40K Hold
6,429
– – ﹤0.01% 419
2016
Q4 		$26K Buy
6,429
+1,429
+29% +$6.63K ﹤0.01% 399
2016
Q3 		$35K Sell
5,000
-11,570
-70% -$192K ﹤0.01% 465
2016
Q2 		$254K Hold
16,570
– – 0.02% 426
2016
Q1 		$259K Buy
16,570
+714
+5% +$9.24K 0.02% 428
2015
Q4 		$194K Hold
15,856
– – 0.02% 457
2015
Q3 		$203K Hold
15,856
– – 0.02% 464
2015
Q2 		$192K Hold
15,856
– – 0.01% 482
2015
Q1 		$210K Hold
15,856
– – 0.01% 486
2014
Q4 		$225K Buy
15,856
+714
+5% +$12.4K 0.01% 482
2014
Q3 		$414K Sell
15,142
-714
-5% -$21.7K 0.03% 416
2014
Q2 		$638K Hold
15,856
– – 0.04% 384
2014
Q1 		$610K Hold
15,856
– – 0.04% 391
2013
Q4 		$539K Sell
15,856
-271
-2% -$7.2K 0.04% 397
2013
Q3 		$307K Sell
16,127
-1,715
-10% -$30K 0.02% 424
2013
Q2 		$276K Buy
+17,842
New +$377K 0.02% 417

Other funds holding FLNA

First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Teton Advisors's FLNA Position: Q2 2017 in Review

Teton Advisors sold out of Filana Therapeutics (FLNA) in Q2 2017, closing a stake of 6,429 shares — an estimated $40K sold.

Teton Advisors first reported a position in FLNA in Q2 2013 and held it in 16 quarters. The position peaked at $638K in Q2 2014. 33 funds tracked by Wall St. Rank hold FLNA as of Q2 2017.

  • Teton Advisors reported no remaining Filana Therapeutics position as of Q2 2017 after selling out during the quarter.
  • Teton Advisors sold 6,429 Filana Therapeutics shares in Q2 2017, an estimated $40K.
  • Teton Advisors first reported a position in Filana Therapeutics in Q2 2013 and held it in 16 quarters.
  • Teton Advisors's Filana Therapeutics position peaked at $638K in Q2 2014.
  • 33 funds tracked by Wall St. Rank held Filana Therapeutics as of Q2 2017.

Based on Teton Advisors's 13F filing for Q2 2017, filed 3 Aug 2017.